SEC Form 4Coverage since Jun 3, 2026
$EDIT insider trading
Over the last 12 months, Editas Medicine insiders reported no purchases and 5 sales totaling $60K across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $60K 5 events
- Events · 12m
- 5 Form 4 filings, grouped
- Insiders · 12m
- 3 distinct reporters
- 10b5-1 share
- 100% pre-arranged plans
Side
Price · $EDIT · 12Mvia TradingView
Top insiders · 12m
Parison AmySVP, Chief Financial Officer2× · $3K
Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER2× · $15K
O'Neill Gilmore NeilCEO1× · $42K
All insider trades
5 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Parison AmySVP, Chief Financial Officer · O | ▼ Sale | 678 | $2.58 | $2K | -4.5% | plan |
| Jul 28, 2026 | Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER · O | ▼ Sale | 4,928 | $2.67 | $13K | -7.3% | plan |
| Jun 3, 2026 | Parison AmySVP, Chief Financial Officer · O | ▼ Sale | 464 | $2.7 | $1K | -3% | plan |
| Jun 3, 2026 | O'Neill Gilmore NeilCEO · O·D | ▼ Sale | 15,380 | $2.7 | $42K | -5.8% | plan |
| Jun 3, 2026 | Burkly LindaEVP, CHIEF SCIENTIFIC OFFICER · O | ▼ Sale | 731 | $2.7 | $2K | -1.1% | plan |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $EDIT feed.